Aviso Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Aviso Financial’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$213K	Sell	476 -2,576	-84%	-$1.2M	0.01%	216
2025 Q4	$1.38M	Sell	3,052 -113	-4%	-$48.7K	0.05%	129
2025 Q3	$1.24M	Buy	3,165 +1,321	+72%	+$552K	0.05%	146
2025 Q2	$821K	Sell	1,844 -6	-0.3%	-$2.77K	0.04%	170
2025 Q1	$897K	Buy	1,850 +647	+54%	+$302K	0.04%	154
2024 Q4	$484K	Buy	1,203 +16	+1%	+$7.42K	0.02%	204
2024 Q3	$552K	Buy	1,187 +222	+23%	+$107K	0.03%	195
2024 Q2	$452K	Buy	+965	New	+$419K	0.03%	191

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Aviso Financial's VRTX Position: Q1 2026 in Review

Aviso Financial reduced its Vertex Pharmaceuticals (VRTX) stake by 84% in Q1 2026, selling an estimated $1.2M and leaving 476 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #216.

Aviso Financial first reported a position in VRTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.38M in Q4 2025. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Aviso Financial held 476 shares of Vertex Pharmaceuticals worth $213K as of Q1 2026.
Aviso Financial sold 2,576 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.2M.
Vertex Pharmaceuticals made up 0.01% of Aviso Financial's portfolio in Q1 2026, its #216 holding.
Aviso Financial first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Aviso Financial's Vertex Pharmaceuticals position peaked at $1.38M in Q4 2025.
1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.